Found: 4
Select item for more details and to access through your institution.
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00383-9
- By:
- Publication type:
- Article
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102066
- By:
- Publication type:
- Article
Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis.
- Published in:
- Nanotheranostics, 2022, v. 6, n. 2, p. 126, doi. 10.7150/ntno.63158
- By:
- Publication type:
- Article
The neutral sphingomyelinase 2 inhibitor PDDC reduces tau burden in Alzheimer's disease mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054502
- By:
- Publication type:
- Article